The proposed mechanisms of action of CBD in epilepsy
RA Gray, BJ Whalley - Epileptic Disorders, 2020 - stm.cairn.info
The proposed mechanisms of action of CBD in epilepsy | Cairn.info Cairn.info, Matières à
réflexion Cairn.info, Matières à réflexion Aucune suggestion trouvée Compte personnel …
réflexion Cairn.info, Matières à réflexion Aucune suggestion trouvée Compte personnel …
Channelopathy of Dravet syndrome and potential neuroprotective effects of cannabidiol
C Xu, Y Zhang, D Gozal… - Journal of Central …, 2021 - journals.sagepub.com
Dravet syndrome (DS) is a channelopathy, neurodevelopmental, epileptic encephalopathy
characterized by seizures, developmental delay, and cognitive impairment that includes …
characterized by seizures, developmental delay, and cognitive impairment that includes …
Cannabidiol: metabolism and clinical efficacy in epileptic patients
GB Dell'Isola, A Verrotti, M Sciaccaluga… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction The landscape of epilepsy treatment has undergone a significant transformation
with the emergence of cannabidiol as a potential therapeutic agent. Epidiolex, a …
with the emergence of cannabidiol as a potential therapeutic agent. Epidiolex, a …
Use of cannabidiol in the treatment of epilepsy
M Mazurkiewicz-Bełdzińska… - … i neurochirurgia polska, 2022 - journals.viamedica.pl
Introduction. Cannabis sativa has been cultivated for human use for about 5,000 years, and
has likewise been used in the treatment of epilepsy for thousands of years. State of the art …
has likewise been used in the treatment of epilepsy for thousands of years. State of the art …
Prophylactic administration of cannabidiol reduces microglial inflammatory response to kainate-induced seizures and neurogenesis
Microglia, the dynamic innate immune cells of the central nervous system, become activated
in epilepsy. The process of microglial activation in epilepsy results in the creation of an …
in epilepsy. The process of microglial activation in epilepsy results in the creation of an …
A Cannabidiol-Regulated MicroRNA Controls Brain Excitability and is a Target for Seizure Control
M Heiland - 2023 - repository.rcsi.com
Epilepsy is a serious neurological disease which is primarily characterised by spontaneous
recurrent seizures, affecting approximately 65 million people worldwide. So far there is still …
recurrent seizures, affecting approximately 65 million people worldwide. So far there is still …
[图书][B] Epilepsy and Canabinoids
A Arzimanoglou, U Brandl, HJ Cross, A Gil-Nagel… - 2020 - books.google.com
Les produits à base de cannabis dans le traitement de diverses maladies, y compris
l'épilepsie, connaissent un essor grandissant, et intéressent de plus en plus les …
l'épilepsie, connaissent un essor grandissant, et intéressent de plus en plus les …
The Effects of Cannabidiol on Microglial Phenotypes and Homeostatic Roles in a Model of Epilepsy
TR Victor - 2021 - search.proquest.com
Microglial involvement in the epileptogenic process and future development of epilepsy has
become increasingly recognized as a potential target for drug intervention in the …
become increasingly recognized as a potential target for drug intervention in the …